During the past decade, International Medical Center of Japan conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Medical Center of Japan" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "International Medical Center of Japan" are "Colorectal Cancer" (2 trials), "HIV Infections" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "International Medical Center of Japan" in a lesser frequency.

Most popular intervention types in "International Medical Center of Japan" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "UFT adjuvant chemotherapy" (2 trials), "adjuvant therapy" (1 trials), "tegafur-gimeracil-oteracil potassium" (1 trials) and "tegafur-uracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Medical Center of Japan" are 4 trials for "All" genders.

Currently, there are NaN active trials in "International Medical Center of Japan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in International Medical Center of Japan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in International Medical Center of Japan, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".